Novel Ingredient Services LLC is sponsoring an independent clinical study of its D-mannose powder, UT-Pro. The study is a follow-up to two recently published clinical trials that found D-mannose significantly supported urinary tract health.
“Given UT-Pro’s superior purity—99%, as measured by HPLC—we believe this branded ingredient will be even more beneficial in managing urinary tract health than generic D-mannose,” says Bob Green, Novel chairman.
Medicus Research, a contract research organization, is conducting the clinical trial and expects to report its results this fall. In related news, a year-long, randomized cross-over study of 60 women, ages 22 to 54, conducted by Daniele Porru, MD, and published in the April, 2014 issue of Journal of Clinical Urology, produced exceptional results for D-mannose, finding it significantly supported urinary tract health.
Likewise, a previous six-month study of 308 women, conducted by Bojana Kranjcec, PhD, and published April, 2013 in World Journal of Urology, had similar findings. UT Pro D-mannose, derived from glucose, offers unrivaled value due to its exceptional purity: 99% by HPLC. To guarantee premium quality, UT Pro is refined using strict Good Manufacturing Practices (cGMPs) that meet international standards, including U.S. Phamacopeial (USP) and British Pharmacopoeia (BP). Novel Ingredient Services is the exclusive distributor of UT-Pro in North America.
Novel Ingredient Services, West Caldwell, N.J., supplies botanical and nutraceutical raw materials. It maintains ISO 9001:1008 certification and registration to the NSF International Dietary Supplement Ingredient Good Manufacturing Practices program. Novel’s international service network includes distribution facilities on the both U.S. coasts, as well as an office in China.—Novel Ingredient Services, www.novelingredient.com